Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
USA117th CongressHRES-484| House
| Updated: 11/1/2022
Mariannette Miller-Meeks
Republican Representative
Iowa
Cosponsors (23)
Bob Gibbs (Republican)Tim Burchett (Republican)Ashley Hinson (Republican)Jefferson Van Drew (Republican)Scott Franklin (Republican)Jeff Duncan (Republican)Jim Jordan (Republican)Jody B. Hice (Republican)Ronny Jackson (Republican)Liz Cheney (Republican)Ann Wagner (Republican)Nancy Mace (Republican)Richard Hudson (Republican)John H. Rutherford (Republican)James Comer (Republican)Mark E. Green (Republican)Mike Bost (Republican)Tom Emmer (Republican)Burgess Owens (Republican)Ralph Norman (Republican)Ted Budd (Republican)Michelle Fischbach (Republican)Nicole Malliotakis (Republican)
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee, Judiciary Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on the Judiciary.
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Commerce
Cardiovascular and respiratory healthCompetitiveness, trade promotion, trade deficitsEmergency medical services and trauma careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntellectual propertyManufacturing
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
USA117th CongressHRES-484| House
| Updated: 11/1/2022
This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on the Judiciary.
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Mariannette Miller-Meeks
Republican Representative
Iowa
Cosponsors (23)
Bob Gibbs (Republican)Tim Burchett (Republican)Ashley Hinson (Republican)Jefferson Van Drew (Republican)Scott Franklin (Republican)Jeff Duncan (Republican)Jim Jordan (Republican)Jody B. Hice (Republican)Ronny Jackson (Republican)Liz Cheney (Republican)Ann Wagner (Republican)Nancy Mace (Republican)Richard Hudson (Republican)John H. Rutherford (Republican)James Comer (Republican)Mark E. Green (Republican)Mike Bost (Republican)Tom Emmer (Republican)Burgess Owens (Republican)Ralph Norman (Republican)Ted Budd (Republican)Michelle Fischbach (Republican)Nicole Malliotakis (Republican)
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee, Judiciary Committee
Commerce
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cardiovascular and respiratory healthCompetitiveness, trade promotion, trade deficitsEmergency medical services and trauma careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntellectual propertyManufacturing